These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 36726987)

  • 21. Characteristics and impact of infiltration of B-cells from systemic sclerosis patients in a 3D healthy skin model.
    Le Maître M; Guerrier T; Collet A; Derhourhi M; Meneboo JP; Toussaint B; Bonnefond A; Villenet C; Sebda S; Bongiovanni A; Tardivel M; Simon M; Jendoubi M; Daunou B; Largy A; Figeac M; Dubucquoi S; Launay D
    Front Immunol; 2024; 15():1373464. PubMed ID: 39185406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.
    Villano M; Borghini A; Manetti M; Gabbrielli E; Rossi A; Sestini P; Milia A; Nacci F; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
    Arthritis Res Ther; 2013 Aug; 15(4):R90. PubMed ID: 23962393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity.
    Matsushita T; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    Rheumatology (Oxford); 2016 Feb; 55(2):263-7. PubMed ID: 26350483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The
    Kavian N; Mehlal S; Jeljeli M; Saidu NEB; Nicco C; Cerles O; Chouzenoux S; Cauvet A; Camus C; Ait-Djoudi M; Chéreau C; Kerdine-Römer S; Allanore Y; Batteux F
    Front Immunol; 2018; 9():1896. PubMed ID: 30177933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of B cells in the pathogenesis of systemic sclerosis.
    Sanges S; Guerrier T; Launay D; Lefèvre G; Labalette M; Forestier A; Sobanski V; Corli J; Hauspie C; Jendoubi M; Yakoub-Agha I; Hatron PY; Hachulla E; Dubucquoi S
    Rev Med Interne; 2017 Feb; 38(2):113-124. PubMed ID: 27020403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Concepts on the Pathogenesis of Systemic Sclerosis.
    Truchetet ME; Brembilla NC; Chizzolini C
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):262-283. PubMed ID: 34487318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities.
    Peng B; Hu Q; He R; Hou H; Lian D; Chen Y; Li H; Song L; Gao Y; Chen T; Zhang G; Li J
    BMC Complement Med Ther; 2023 Feb; 23(1):62. PubMed ID: 36810081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
    MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
    J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
    François A; Chatelus E; Wachsmann D; Sibilia J; Bahram S; Alsaleh G; Gottenberg JE
    Arthritis Res Ther; 2013 Oct; 15(5):R168. PubMed ID: 24289101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Fibronectin Levels in Profibrotic CD14
    Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
    Front Immunol; 2021; 12():642891. PubMed ID: 34504485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New developments in the pathogenesis of systemic sclerosis.
    Sakkas LI
    Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of connective tissue synthesis in systemic sclerosis.
    Varga J; Bashey RI
    Int Rev Immunol; 1995; 12(2-4):187-99. PubMed ID: 7650421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib.
    Ricard L; Jachiet V; Malard F; Ye Y; Stocker N; Rivière S; Senet P; Monfort JB; Fain O; Mohty M; Gaugler B; Mekinian A
    Ann Rheum Dis; 2019 Apr; 78(4):539-550. PubMed ID: 30760472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis.
    Choreño-Parra JA; Cervantes-Rosete D; Jiménez-Álvarez LA; Ramírez-Martínez G; Márquez-García JE; Cruz-Lagunas A; Magaña-Sánchez AY; Lima G; López-Maldonado H; Gaytán-Guzmán E; Caballero A; Fernández-Plata R; Furuzawa-Carballeda J; Mendoza-Milla C; Navarro-González MDC; Llorente L; Zúñiga J; Rodríguez-Reyna TS
    Rheumatology (Oxford); 2023 Apr; 62(4):1687-1698. PubMed ID: 36063053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunopathological disturbances in systemic sclerosis].
    Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
    Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunopathogenesis of fibrosis in systemic sclerosis.
    Brown M; O'Reilly S
    Clin Exp Immunol; 2019 Mar; 195(3):310-321. PubMed ID: 30430560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.
    Matsushita T; Kobayashi T; Mizumaki K; Kano M; Sawada T; Tennichi M; Okamura A; Hamaguchi Y; Iwakura Y; Hasegawa M; Fujimoto M; Takehara K
    Sci Adv; 2018 Jul; 4(7):eaas9944. PubMed ID: 30009261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.